Methods of Inhibiting Vascular Permeability and Apoptosis
Agonists of vascular endothelial sphingosine-1-phosphate receptors are described. Compounds such as FTY720 can be phosphorylated by sphingosine kinase-2 into the phosphorylated forms which serve as sphingosine-1-phosphate receptor agonists. The vascular endothelial sphingosine-1-phosphate receptor agonists are employed in methods of treating a mammal for vascular permeability disorders and unwanted vascular endothelial cell apoptosis, and for the growth of new blood vessels. The sphingosine-1-phosphate receptor agonists can be used for the manufacture of a medicament for treating vascular permeability disorders and unwanted vascular endothelial cell apoptosis, and for the growth of new blood vessels.
Attached files:Patents:US 20,100,025,660
Inventor(s):
JAIN FAQUIR C [US]; PAPADIMITRAKOPOULOS FOTIOS [US]
Type of Offer:
Licensing
« More Biotech Patents